Validating VIL-6 as a target for KSHV-associated disease

Medicine & Life Sciences

1. Human Herpesvirus 8 100%
2. Simian Immunodeficiency Virus 54%
3. Interleukin-6 49%
4. enhanced green fluorescent protein 39%
5. B-Lymphocytes 24%
6. Viral DNA 23%
7. Macaca 23%
8. Virus Diseases 23%
9. Genetic Recombination 20%
10. Hyperplasia 18%
11. Primary Effusion Lymphoma 16%
12. Bone Marrow Examination 14%
13. Viruses 14%
14. DNA Restriction Enzymes 13%
15. Genes 12%
16. Phenotype 12%
17. Kaposi's Sarcoma 12%
18. Herpesviridae 12%
19. Viral Genome 12%
20. Southern Blotting 11%
21. Macaca mulatta 11%
22. Biological Assay 11%
23. Leukocyte Count 10%
24. Viral Load 10%
25. Electrophoresis 10%
26. Sequence Analysis 9%
27. Digestion 9%
28. Blood Proteins 9%
29. Physical Examination 9%
30. Acquired Immunodeficiency Syndrome 8%
31. Lymphoma 8%
32. Intercellular Signaling Peptides and Proteins 8%
33. Plasmids 8%
34. Lymph Nodes 7%
35. Enzyme-Linked Immunosorbent Assay 7%
36. Neoplasms 6%
37. Biopsy 6%
38. Polymerase Chain Reaction 6%
39. Mutation 5%